	Association of mobile application information on multidisciplinary therapy and treatment compliance in early-stage breast cancer: A prospective multicenter randomized phase III study. Breast Zhu S, Li S, Qu R, Ren W, Hu C, Chen X. PMID: 42150214 [PubMed - as supplied by publisher]
	Impact of Multicancer Screening on Late-Stage Cancer at Diagnosis in Breast Cancer Survivors: A Modeling Study. JCO Precis Oncol Gogebakan KC, Lange J, Gulati R, Dubard-Gault ME, Drescher CW, Malone KE, Etzioni R. PMID: 42150149 [PubMed - indexed for MEDLINE]
	Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer. J Clin Oncol Gluz O, Nitz UA, Christgen M, Kuemmel S, Holtschmidt J, Schumacher J, Raeth P, Hartkopf AD, Luedtke-Heckenkamp K, Just M, von Schumann R, Polata S, Schinkoethe T, Graeser MK, Kates R, Wuerstlein R, Harbeck N. PMID: 42150145 [PubMed - as supplied by publisher]
	Integrated Community-Clinic Model of Optimized Implementation Strategies to Increase Early Detection of Breast and Cervical Cancers in Kenya: Protocol for a Pragmatic Randomized Controlled Trial. JMIR Res Protoc Gakunga R, Mburu L, Ali Z, Krudy M, Inziani M, Katua D, Kerich C, Agoro O, Subramanian S. PMID: 42149806 [PubMed - indexed for MEDLINE]
	The emerging importance of TNF-Î± in canine mammary cancer: A narrative overview. Acta Vet Hung Arora R, Tyagi A. PMID: 42149662 [PubMed - as supplied by publisher]
	Artificial intelligence for risk-stratified breast cancer screening: a systematic review of evidence, clinical integration, and ethical implications in risk assessment tools. Radiol Med Pesapane F, Caumo F, Mantellini P, Irmici G, Depretto C, Penco S, Rotili A, Trentin C, Dominelli V, Corso G, Magnoni F, Lazzeroni M, Santicchia S, Scaperrotta GP, Cassano E. PMID: 42149286 [PubMed - as supplied by publisher]
	Mapping supportive-care evidence for febrile neutropenia prevention in breast cancer chemotherapy: a bibliometric analysis of long-acting G-CSF prophylaxis. Support Care Cancer Li S, Shang Y, Yuan X, Cheng Y, Miao YD, Zhang W. PMID: 42149261 [PubMed - indexed for MEDLINE]
	A Feasibility Study of Trans-Arterial Chemoembolization as a First-Line Treatment for Locally Advanced Breast Cancer. Cardiovasc Intervent Radiol Kuzumi R, Hori S, Hori A, Takeuchi M, Dejima I, Nakamura T. PMID: 42149172 [PubMed - as supplied by publisher]
	Current Landscape of Anti-HER2 Targeted Therapy in Breast Cancer: Challenges and Future Perspectives. Cancer Invest Bharali P, Mehta V, Chand S, Chander H. PMID: 42148547 [PubMed - as supplied by publisher]
	The Effect of Group Counselling on Body Image and Sexual Satisfaction Among Women with Breast Cancer: A Randomized Clinical Trial. Cancer Invest Vakili F, Khadivzadeh T, Asgharinekah M, Homaei Shandiz F, Taghi Shakeri M. PMID: 42148476 [PubMed - as supplied by publisher]
	Severe neuromyelitis optica spectrum disorder induced by pucotenlimab: a case report and literature review. Front Immunol Zhang Z, Liao L, Zhou H, Xiang W, Li J. PMID: 42148066 [PubMed - indexed for MEDLINE]
	Yttrium-90 for the treatment of breast cancer liver metastases: a global propensity-matched study. Proc (Bayl Univ Med Cent) Miles B, Mallepally A, Oza Q, Moss J. PMID: 42148015 [PubMed - indexed for MEDLINE]
	Dual-discriminator network-based classification method for breast ultrasound imaging. Quant Imaging Med Surg Zhao X, Zhao H, Cheng Z. PMID: 42147959 [PubMed]
	Higher perfusion among breast malignant tumors than among breast benign lesions as demonstrated by diffusion-derived 'vessel density' (DDVD): a pilot study. Quant Imaging Med Surg Liu ZY, Yao DQ, Wáng YXJ, Xiong YM, Dai Y, Li CY, Luo L, Du HY, Zhang LY. PMID: 42147910 [PubMed]
	Diagnostic performance of contrast-enhanced mammography and MRI for breast non-mass microcalcifications: a novel Malignant Calcification Score in contrast-enhanced mammography. Quant Imaging Med Surg Chen J, Hua B, Zhao Y, Li Q, Liu Y, Zhao D, Yang G, Yao S, Ping Y. PMID: 42147903 [PubMed]
	The clinicopathological and imaging parameters contributing to the similarity network fusion subtypes and prognosis of hormone receptor-positive HER2-negative breast cancer: an exploratory study. Quant Imaging Med Surg Hou R, Li J, Meng X, Zhang M, You Z, Zhang K, Li J. PMID: 42147893 [PubMed]
	Development and validation of radiomics models for the diagnoses of breast lesions with calcification on ultrasound. Quant Imaging Med Surg Wang X, Zhang N, Ma J, Qin W, Liao S, Chang H, Liu J, Huo L. PMID: 42147876 [PubMed]
	Integrative Mendelian Randomization and Multiomics Analysis Identifies CAF-Derived Complement Factor B as a Prognostic Biomarker and Therapeutic Vulnerability in Breast Cancer. Hum Mutat Xiang H, Ren N, Wang T, Zheng X, Kang Z, Dong Y. PMID: 42147810 [PubMed - indexed for MEDLINE]
	Triple-negative breast cancer: current understanding and future perspectives. Explor Target Antitumor Ther Alobaidi A, Rai V. PMID: 42147479 [PubMed]
	Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced/Metastatic Breast Cancer. World J Oncol Savvidou , Constantinidou A, Zacharia L, Michailidou K, Zanti , Kitiri S, Marcou Y, Konstantinou I, Kakouri E, Galazi M, Petrou C. PMID: 42147265 [PubMed]

Articles 1 - 20 / 217750

Page 1 of 10888



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy